NCT06167486 2026-03-09SG2918 For Advanced Malignant TumorsHangzhou Sumgen Biotech Co., Ltd.Phase 1 Active not recruiting17 enrolled
NCT05193721 2024-03-20A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant TumorsSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1 Active not recruiting25 enrolled